// App-Quantinova.ai

2683 : Factors Associated with Disease Progression in Early-Diagnosed Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

Researchers

Presenter

  • Carina Mihai

Principal Investigators

  • Milos Antic

  • Rucsandra Dobrota

  • Diana Bonderman

  • Harbajan Chadha-Boreham

  • J. Gerry Coghlan

  • Christopher Denton

  • Martin Doelberg

  • Ekkehard Gruenig

  • Dinesh Khanna

  • Vallerie McLaughlin

  • Ulf Mller-Ladner

  • Janet E. Pope

  • Daniel M Rosenberg

  • James R Seibold

  • Madelon C Vonk

  • Oliver Distler

Medical Centers

  • Internal Medicine and Rheumatology Department Sf. Maria Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

  • Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

  • Department of OB/GYN, Division of Senology, Medical University of Vienna, Vienna, Austria

  • Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

  • National Pulmonary Hypertension Service, Hammersmith Hospital, London, United Kingdom,

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Centre for Pulmonary Hypertension, Thoraxclinic, University Hospital Heidelberg, Heidelberg, Germany

  • Internal Medicine, Division of Rheumatology and Clinical Autoimmune Center of Excellence, University of Michigan, Ann Arbor, MI, Ann Arbor, MI

  • Division of Cardiology, University of Michigan, Ann Arbor, MI

  • Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Bad Nauheim, Germany

  • Department of Medicine, Division of Rheumatology, University of Western Ontario, St. Joseph’s Health Care, London, ON, Canada,

  • Scleroderma Research Consultants LLC, Litchfield, CT

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

Locations

  • Romania

  • Switzerland

  • Austria

  • United Kingdom

  • Germany

  • United States

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved